Pfizer Plans R&D, Manufacturing Expansion In Asia
This article was originally published in PharmAsia News
Executive Summary
In another indication of big pharma's expanding interest in Asia, Pfizer announced Nov. 30 that it will seek to increase the amount of R&D and manufacturing it does in that part of the world
You may also be interested in...
Japan's Otsuka Holds Talks With Korean Government On R&D Project
SEOUL - The Korean unit of Japan's Otsuka Pharmaceuticals is holding negotiations with South Korea's Ministry for Heath, Welfare and Family Affairs on investing in drug research and development, and the two sides could soon sign a memorandum of understanding, according to a Korea Otsuka executive
Japan's Otsuka Holds Talks With Korean Government On R&D Project
SEOUL - The Korean unit of Japan's Otsuka Pharmaceuticals is holding negotiations with South Korea's Ministry for Heath, Welfare and Family Affairs on investing in drug research and development, and the two sides could soon sign a memorandum of understanding, according to a Korea Otsuka executive
More Than Half Of Trials Conducted In South Korea Led By Pfizer
SEOUL - The number of clinical trials Pfizer Korea conducted in South Korea last year rose sharply to 93 cases from 75 cases in 2007, a result of Pfizer's move to conduct more of its clinical trials in South Korea